دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش: سری: ISBN (شابک) : 9781405157476, 9781444300857 ناشر: BMJ Books سال نشر: 2008 تعداد صفحات: 426 زبان: English فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) حجم فایل: 15 مگابایت
در صورت تبدیل فایل کتاب Evidence-Based Hematology به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب هماتولوژی مبتنی بر شواهد نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
This unique new book uses a series of focussed questions,
comprehensive literature evaluations and structured grades of
recommendation to provide evidence for the treatment of
hematological disorders, both malignant and benign. With
contributions from leading international experts who have a
real understanding of evidence-based medicine the book provides
comprehensive reviews accompanied by clinical commentaries and
recommendations on the best treatment regimes to adopt for
individual patients.
The book is split into two sections: the first examines the
methodology underlying evidence based practice, and the second
concentrates on the clinical practice of hematology, providing
current “best evidence” to guide practice in a series of
well-defined clinical situations.
This clinical reference is an invaluable source of
evidence-based information distilled into guidance for clinical
practice which will be welcomed by practitioners, trainees and
associated health professionals.Content:
Chapter 1 Rating the Quality of Evidence and Making
Recommendations: A Guide to the Spectrum of Clinical Research
(pages 1–9): Holger J. Schunemann, Martin Stanulla, Jan L.
Brozek and Gordon G. Guyatt
Chapter 2 An Overview of Systematic Reviews (pages 10–14):
Martin Prins, Arina ten Cate?Hoek and Pieter Leffers
Chapter 3 Interpreting Results in Clinical Research: Overview
of Measures of Effect, Measures of Precision, and Measures of
Diagnostic Accuracy for Clinicians and Researchers (pages
15–22): Marcello Di Nisio, Harry R. Buller and Patrick M. M.
Bossuyt
Chapter 4 Finding the Evidence in Hematology (pages 23–31): K.
Ann McKibbon, Cynthia J. Walker?Dilks and R. Brian Haynes
Chapter 5 Applying EBM in Clinical Practice (pages 32–36):
Alessandro Squizzato, Walter Ageno and Davide Imberti
Chapter 6 Using Evidence to Guide the Diagnosis of Disease
(pages 37–45): Lucas M. Bachmann and Holger J. Schunemann
Chapter 7 Diagnosis of Deep Vein Thrombosis (pages 47–55):
Lori?Ann Linkins
Chapter 8 The Diagnosis of Acute Pulmonary Embolism (pages
56–64): Victor F. Tapson
Chapter 9 Initial Therapy of Deep Vein Thrombosis and Pulmonary
Embolism (pages 65–72): Sam Schulman
Chapter 10 Long?Term Anticoagulation in Venous Thromboembolism
(pages 73–87): Clive Kearon
Chapter 11 Thrombolytic Therapy for Deep Vein Thrombosis and
Pulmonary Embolism (pages 88–98): Simon J. McRae and John W.
Eikelboom
Chapter 12 Inferior Vena Cava Interruption (pages 99–109):
Michael B. Streiff and Christine L. Hann
Chapter 13 Management of Venous Thromboembolism in Pregnancy
(pages 110–119): Wee?Shian Chan
Chapter 14 Pediatric Thrombosis (pages 120–123): Anthony K. C.
Chan and Paul Monagle
Chapter 15 Bridging Anticoagulation in Patients Who Require
Temporary Interruption of Warfarin for Surgery (pages 124–130):
James D. Douketis and Scott Kaatz
Chapter 16 Evidence?Based Approach to the Diagnosis and
Management of Thrombotic Thrombocytopenic Purpura (pages
131–137): Brian Boulmay and Craig S. Kitchens
Chapter 17 Diagnosis and Management of Disseminated
Intravascular Coagulation (pages 138–144): Julia A. M.
Anderson
Chapter 18 Diagnosis and Management of Hereditary Bleeding
Disorders: Including Congenital/Acquired Platelet Function
Disorders (pages 145–151): Nigel S. Key and Alice D. Ma
Chapter 19 Diagnosis and Management of Acquired Bleeding
Disorders: Vitamin K Antagonists (pages 152–157): Miguel A.
Escobar
Chapter 20 Diagnosis and Management of Heparin?Induced
Thrombocytopenia (pages 158–167): Theodore E. Warkentin and
Andreas Greinacher
Chapter 21 Management of Antiphospholipid Antibody Syndrome
(pages 168–175): Wendy Lim and Mark A. Crowther
Chapter 22 Clinical Questions in Iron Overload (pages 177–188):
Antonello Pietrangelo and Nicola Magrini
Chapter 23 Aplastic Anemia, Paroxysmal Nocturnal
Hemoglobinuria, and Pure Red Cell Aplasia (pages 189–196):
Shivani Srivastava and Richard W. Childs
Chapter 24 Acquired Anemias: Iron Deficiency, Cobalamin
Deficiency, and Autoimmune Hemolytic Anemia (pages 197–205):
Marc S. Zumberg and Marc J. Kahn
Chapter 25 Immune Thrombocytopenic Purpura (pages 206–214):
James N. George, Sara K. Vesely and George R. Buchanan
Chapter 26 Neutropenia (pages 215–220): David C. Dale
Chapter 27 Hypereosinophilia: Primary and Secondary (pages
221–228): Florence Roufosse, Michel Goldman and Elie
Cogan
Chapter 28 Porphyrias (pages 229–237): Gagan Sood and Karl E.
Anderson
Chapter 29 Membrane and Enzyme Abnormalities of the Erythrocyte
(pages 238–243): Patrick G. Gallagher and Ernest Beutler
Chapter 30 Sickle Cell Disease (pages 244–250): Richard
Lottenberg and Sally C. Davies
Chapter 31 Evidence?Based Treatment of Thalassemia Major (pages
251–259): Issac Odame and Deborah Rund
Chapter 32 Acute Lymphoblastic Leukemia in Adults (pages
261–267): Stephen Couban and Andrea Kew
Chapter 33 Acute Myeloid Leukemia in Adults: Remission
Induction Therapy (pages 268–277): Cara A. Rosenbaum and
Richard A. Larson
Chapter 34 Acute Myeloid Leukemia in Adults: Postremission
Therapy (pages 278–286): Cara A. Rosenbaum and Richard A.
Larson
Chapter 35 Current Areas of Controversy in the Treatment of
Patients with Newly Diagnosed Acute Promyelocytic Leukemia
(pages 287–293): Martin S. Tallman and Syed A. Abutalib
Chapter 36 Chronic Lymphocytic Leukemia (pages 294–299): Bruce
D. Cheson
Chapter 37 Chronic Myeloid Leukemia (pages 300–304): Irwin
Walker
Chapter 38 Selected Management of Patients with Myelodysplastic
Syndromes (pages 305–310): John M. Storring and Karen W. L.
Yee
Chapter 39 Evidence?Based Treatment of Burkitt Lymphoma in
Adults (pages 311–316): John Gerecitano and David J.
Straus
Chapter 40 Primary Central Nervous System Lymphoma (pages
317–326): Tamara Shenkier
Chapter 41 Diffuse Large B?Cell Lymphoma (pages 327–333):
Michael Crump
Chapter 42 Follicular Lymphoma (pages 334–341): Kevin Imrie and
Matthew Cheung
Chapter 43 Lymphoblastic Lymphoma (pages 342–346): Tyler Y.
Kang and John W. Sweetenham
Chapter 44 Mantle Cell Lymphoma (pages 347–351): C. Tom
Kouroukis
Chapter 45 Management of Patients with Peripheral T?Cell
Lymphoma (pages 352–364): Kerry J. Savage
Chapter 46 Selected Management Issues of Patients with Hodgkin
Lymphoma (pages 365–371): Ralph M. Meyer
Chapter 47 Lymphocyte Predominant Hodgkin Lymphoma (pages
372–377): Brandon McMahon and Jonathan W. Friedberg
Chapter 48 Management of Patients with Essential
Thrombocythemia (pages 378–384): Guido Finazzi, Giovanni Barosi
and Tiziano Barbui
Chapter 49 Management of Patients with Polycythemia Vera (pages
385–389): Guido Finazzi, Roberto Marchioli and Tiziano
Barbui
Chapter 50 Evidence?Based Review of Therapies in Multiple
Myeloma (pages 390–395): Michael Sebag and A. Keith
Stewart
Chapter 51 Management of Waldenstrom's Macroglobulinemia (pages
396–401): Christine I. Chen
Chapter 52 The Role of Hematopoietic Growth Factors in Managing
Patients with Hematologic Malignancies (pages 402–411): Heloisa
P. Soares, Ambuj Kumar, Charles Bennett and Benjamin
Djulbegovic